Clinical Efficacy or Tildrakizumab in Patients with Chronic Plaque Psoriasis Over 2 Years of Treatment: Results from Long-Term Extensions to 2 Phase 3 Clinical Studies

Open Access
Publisher Website
Google Scholar
Abstract
Not available. Study supported by Merck & Co., Inc.